Enter your keywords
HOME
About Us
NEWSLETTER
To search AlzRisk, use the "Keyword" search on the
AlzRisk search page
.
NEWS
All News
Conference Coverage
Series
WEBINARS
All Webinars
Databases
AlzBiomarker
AlzPedia
AlzRisk
Antibodies
Genetics
AlzGene
HEX
Mutations
Protocols
Research Models
Therapeutics
PAPERS
All Papers
Papers of the Week
Milestone
Alzforum Recommends
PROFESSIONAL RESOURCES
Conference Calendar
Grants
Jobs
Member Directory
ABOUT AD
AD Overview
Early-Onset Familial
The HBO Alzheimer's Project
Supported Browsers
MY ALZFORUM
My AlzForum Home
View Library
View Notifications
Set Notifications
Edit Profile
AlzRisk Paper Detail
Risk Factors
Alcohol
B Vitamins
Blood Pressure
Cognitive Activity
Diabetes Mellitus
Dietary Pattern
Head injury
Homocysteine
Hormone Therapy
Inflammatory Biomarkers
Non-Steroidal Anti-Inflammatory Drugs
Nutritional Antioxidants
Obesity
Physical Activity
Statin use
Reference:
Gray, 2008
Cohort:
Adult Changes in Thought-Group Health Cooperative
Risk Factor:
Nutritional Antioxidants
Average Follow-up Time Detail
We estimated average person-years of follow-up by multiplying the reported average follow-up time by the number of persons. In addition, this estimate pertains to the analysis of total dementia, but should be reasonably similar for the analysis of AD.
Exposure Detail
Assessed by in-person interview at baseline. Both vitamin C and multivitamins were assessed, but vitamin C use was defined as taking vitamin C-only supplements. Use was considered taking vitamin C supplements during at least one week of the previous month. The reference category consisted of those taking no supplemental vitamin C or E and no multivitamins.
Important Note: This table includes results for only 2 categories of vitamin C use, to the exclusion of participants in other categories (e.g., any vitamin E, any multivitamin use). Therefore, the percents shown do not add up to 100%.
Ethnicity Detail
"Other" ethnicities were not specified beyond not being Caucasian.
Screening and Diagnosis Detail
Screening Method:
CASI
Cognitive Abilities Screening Instrument (Teng 1994)
AD Diagnosis:
NINCDS ADRDA
National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association Criteria (McKhann 1984)
Total Dementia Definition
: Dementia via DSM IV.
"Participants were rescreened using the CASI every 2 years to assess changes in cognitive function. Participants whose CASI scores fell below 86 underwent a standardized dementia diagnostic evaluation including a physical and neurological examination by a study neurologist, geriatrician, or internist and a 1-hour battery of neuropsychological testing. Relevant laboratory tests and brain computed tomography or magnetic resonance imaging studies were performed, or results were obtained from GHC records. Diagnoses were assigned at consensus diagnostic conferences using the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for dementia (12) and the criteria of the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer’s Disease and Related Disorders Association for AD (13). Participants with new-onset dementia underwent at least one annual follow-up examination for verification of dementia status. For these analyses, the two outcomes included any dementia and possible or probable AD."
Covariates & Analysis Detail
Analysis Type:
Cox proportional hazards regression
Age was the time scale in the proportional hazards analysis. Education was modeled as years of education.
AD Covariates:
A
age
E
education
G
gender
CHD
coronary heart disease
HS
health status
PA
physical activity
SM
smoking status
TD Covariates:
A
age
E
education
G
gender
CHD
coronary heart disease
HS
health status
PA
physical activity
SM
smoking status